- 57
- 18 601
The Aplastic Anemia & Myelodysplasia Association of Canada (AAMAC)
Registrace 28. 10. 2014
BMT 101: The basics of allogeneic hematopoietic cell transplantation
Webinar lead by Dr Ivan Pasic on January 24, 2024 Dr. Ivan Pasic, FRCPC
About the speaker:
Dr. Pasic is a staff physician and clinician investigator in the Hans Messner Allogeneic Transplant Program at Princess Margaret Hospital. He obtained his MD and PhD degrees in 2012 and subsequently completed residencies in internal medicine and medical oncology in 2016 and 2017 at the University of Toronto. He went on to complete a fellowship in allogeneic hematopoietic cell transplantation in the Hans Messner Allogeneic Transplant Program in 2019. During his fellowship, he served as the chief transplant and malignant hematology fellow physician during the 2018-2019 academic year. Throughout his career he always had a keen interest in research. The work on his doctoral thesis on biomarker discovery in paediatric cancers was published in Cancer Research. His current basic science research interest is in the characterization of factors influencing transplant-related complications such as graft-vs-host disease and relapse. He recently published a study describing the discovery of novel biomarkers of acute graft-vs-host disease in allogeneic hematopoietic transplant recipients. On the clinical side, Dr. Pasic focuses on the characterization of factors impacting transplant-related complications, with a particular emphasis on the use of novel conditioning regimens designed to reduce transplantation-related mortality. He is an author on over 50 peer-reviewed studies. He is a sitting member on the institutional Oncology Research Ethics Board. During COVID-19 pandemic, he was a member of the Princess Margaret Hospital COVID-19 Vaccine Guidance Committee, which released institutional evidence-based guidance to vaccination of oncology patients against SARS-CoV-2.
About the speaker:
Dr. Pasic is a staff physician and clinician investigator in the Hans Messner Allogeneic Transplant Program at Princess Margaret Hospital. He obtained his MD and PhD degrees in 2012 and subsequently completed residencies in internal medicine and medical oncology in 2016 and 2017 at the University of Toronto. He went on to complete a fellowship in allogeneic hematopoietic cell transplantation in the Hans Messner Allogeneic Transplant Program in 2019. During his fellowship, he served as the chief transplant and malignant hematology fellow physician during the 2018-2019 academic year. Throughout his career he always had a keen interest in research. The work on his doctoral thesis on biomarker discovery in paediatric cancers was published in Cancer Research. His current basic science research interest is in the characterization of factors influencing transplant-related complications such as graft-vs-host disease and relapse. He recently published a study describing the discovery of novel biomarkers of acute graft-vs-host disease in allogeneic hematopoietic transplant recipients. On the clinical side, Dr. Pasic focuses on the characterization of factors impacting transplant-related complications, with a particular emphasis on the use of novel conditioning regimens designed to reduce transplantation-related mortality. He is an author on over 50 peer-reviewed studies. He is a sitting member on the institutional Oncology Research Ethics Board. During COVID-19 pandemic, he was a member of the Princess Margaret Hospital COVID-19 Vaccine Guidance Committee, which released institutional evidence-based guidance to vaccination of oncology patients against SARS-CoV-2.
zhlédnutí: 662
Video
Caring for Care Partners: Addressing Burnout and Compassion Fatigue
zhlédnutí 42Před 8 měsíci
Recording of presentation given by Celeigh Barber-Russell, Clinical Counsellor, B.Ed, M.Ed, LCT-C, CCC on Nov 18, 2023
MDS and New Treatment Options - Dr. Jenny Ho
zhlédnutí 954Před 8 měsíci
Recording of presentation given by Jenny Ho, MD, MSC, FRCPC Assistant Professor, Schulich School of Medicine and Dentistry, Western University on Nov 4, 2023
Paroxysmal Nocturnal Hemoglobinuria & Aplastic Anemia - Monika Oliver BSc MD FRCPC
zhlédnutí 362Před rokem
Recording of presentation given by Monika Oliver BSc MD FRCPC Division of Apheresis Medicine, Division of Hematology, University of Alberta Hospital at the meeting in Toronto on April 22, 2023
MDS: New Developments - Karen Yee, MD, MSc, FRCP(C) UN - Princess Margaret Cancer Centre
zhlédnutí 696Před rokem
Recording of Toronto Meeting - April 22, 2023
The old and the new in MDS management
zhlédnutí 2,4KPřed rokem
MDS presentation with Dr Dina Khalaf, a hematologist at the Juravinski Cancer Centre on February 9, 2023
Sexual Health and Intimacy in the Context of Serious Illness
zhlédnutí 55Před rokem
Recording of webinar from January 24, 2023 with Reanne Booker ABOUT THE SPEAKER Reanne is an oncology and palliative care nurse practitioner with over 20 years’ experience in nursing. She works with the Palliative and End-of-Life Care Services Program in Calgary, Alberta and the Medical Assistance in Dying Program. Her clinical and research interests include the integration of palliative care i...
Addressing PNH unmet medical needs: a policy roadmap to aspire for change
zhlédnutí 90Před rokem
A recording of a multi-stakeholder online conference held on December 7, 2022 and organised by Partnering4PNH, a global multistakeholder policy initiative which brings together PNH specialised healthcare professionals, nurses, patients and patient organisations from Europe, Canada and Australia. Confirmed speakers will include: * MEP István Ujhelyi (S&D, Hungary) * MEP Stelios Kympouropoulos (E...
Iron Overload Management
zhlédnutí 645Před rokem
Recording of webinar on Saturday November 26, 2022 at11 AM (Eastern Time (ET)) with Dr Hsia Unfortunately due to technical difficulties, the start of the webinar was not properly recorded so has been cut from the recording. Apologies for any inconvenience. Objectives: * Understand the importance of iron in the body * Review the toxicity of iron to organs as a result of chronic red blood cell tr...
Self Compassion for Caregivers
zhlédnutí 36Před rokem
Date: November 22, 2022 Time: 2 pm (Eastern Time (ET)) Speaker: Patricia Williams You may wonder why this webinar focuses on self-compassion? Research has shown that caregivers are often at risk for stress, burnout, depression, and other health challenges. We also know that the demanding role of caregiver can negatively impact our sense of wellbeing and quality of life. So why self-compassion? ...
MDS - New and Emerging Treatments
zhlédnutí 2KPřed rokem
Webinar Date: Monday October 17, 2022 Time: 1PM (CT) | 2PM (ET) Speaker: Brett Houston, MD, PhD
MEP Stelios Kympouropoulos
zhlédnutí 91Před rokem
Watch MEP Stelios Kympouropoulos, the co-chair of Partnering4PNH talk about the importance of such partnerships to spark public debate and change the quality of life for people living PNH.
Psychosocial Aspects of Care amidst a Pandemic (Patients and Carers)
zhlédnutí 13Před rokem
Date: September 27, 2022 Time: 2:00 p.m. (Eastern Time) Speaker: Jocelyn Lepage
Transitioning from Pediatric to Adult Care Inherited Bone Marrow Failure Syndromes
zhlédnutí 68Před rokem
Date: Thursday September 8, 2022 Time: 7PM (ET) Speaker: Dr. Yves Pastore Clinical Associate Chu Sainte-Justine Pediatrics Department, Hematology Department Objectives: Please join us for a discussion and update of a national initiative to promote care for adults with inherited bone marrow failure syndromes in Canada as patients transition from pediatric to adult care in the health care system.
Research Priorities in MDS: A Survey of Canadian Patients, Caregivers and Clinicians
zhlédnutí 26Před 2 lety
Webinar Date: May 3, 2022 Speaker: Grace Christou, MSc, MD, FRCPC Hematologist, Leukemia Program Division of Hematology, The Ottawa Hospital Clinician Investigator, Clinical Epidemiology Program Ottawa Hospital Research Institute Assistant professor of Medicine, University of Ottawa
Patient Oriented Research and Patient Engagement in Clinical Trials An Introduction
zhlédnutí 47Před 2 lety
Patient Oriented Research and Patient Engagement in Clinical Trials An Introduction
MDS Treatment - Side Effect Management & Ask a Hematologist
zhlédnutí 792Před 2 lety
MDS Treatment - Side Effect Management & Ask a Hematologist
Community Supports What do you need How to find it
zhlédnutí 22Před 2 lety
Community Supports What do you need How to find it
Webinar - INQOVI®: Everything you want to know about it and other MDS treatments.
zhlédnutí 1KPřed 2 lety
Webinar - INQOVI®: Everything you want to know about it and other MDS treatments.
Understanding the Drug Approval Process in Canada
zhlédnutí 299Před 2 lety
Understanding the Drug Approval Process in Canada
Cytogenetics and Molecular Testing in MDS
zhlédnutí 480Před 3 lety
Cytogenetics and Molecular Testing in MDS
Nurturing Your Holistic Wellbeing: The Psychosocial Impacts of Living with a Chronic Illness
zhlédnutí 29Před 3 lety
Nurturing Your Holistic Wellbeing: The Psychosocial Impacts of Living with a Chronic Illness
Update on Changes to Drug Pricing Regulations in Canada
zhlédnutí 31Před 3 lety
Update on Changes to Drug Pricing Regulations in Canada
Thank you this was very helpful in 5 2024 when my family member was just diagnosed with high risk mds they want to use decitabine with the venetoclax in a port. Scary.
Insurance doesn’t cover decitabine on part d Medicare. If they do it’s thousands of dollars each treatment. USA sucks on medication under Medicare
If low risk MDS does not respond to any of the treatment then what options..in my case have taken all treatment but still transfusion dependent every month.
Hoh much risky?age 65yrs. Case MDS del 20q
my mom got diagnosed with MDS , her blood counts have dropped by a lot within 6 months , bone marrow biopsy reveled gene mutation , dr said its mild ATM , not sure the score is ,. i came across your video , now i understand better what we are dealing with , i was overwhelmed first didnt understand what this disese was , im less nervous and at little ease , thank you so much .
Promo>SM
I am a 51 year young bone marrow transplant , Aplastic Anemia patient. My own Momma was My Donner. But it wasn't a100 percent a match. I was about 12 when I was diagnosed with AA. Alll 3 of My cells would bottom out almost everyday! More & more O-Neg & Platelet transfusions though all of these years! 8:32 My Momma gave Me birth twice ! I Love You Momma. Thank You for everything. I sure do miss Her. I was diagnosed in 1985-1986. I had the FIRST bone marrow transplant from Mother to child! EVER !! Now, I' live by matninse treatments, and more blood. My BM is so dry, that My Dr couldn't even get a biopsy after He biopsied Me 3 freaking times in 2 and a half hours ! They tried to dope me up, when My Dr wouldn't have put Me out. I even bit a intern Dr one time. I am getting ready to write about My life STILL with Aplastic Anemia. I've fought My entire life, and I STILL AM. I don't have a hematologist ever since I changed My insurance. Anyway, if You have or still have AA, I would like to chat with a AA Doctor, before My hemoglobin and platelets go down any further. Thanks for reading My babble. LOL ! I live here in Florida, and I am ALWAYS COLD ! Have a Awesome Christmas everybody ! Stay warm, and God bless.
Excellent presentation. Using cartoons to explain complex oncology topics is very interesting approach. I appreciate the presenter and the organizers for their dedication. Thanks for sharing it in open access. Best Wishes Dr Krishna
Liked and fully watched! You are missing out on potential viewers by not using a service such as smzeus.
my brother Mr Anil gagrae suffering from aplastic anaemia last 2 years and his blood platelets count is 55000 only mam can he take coronavirus vaccine and it's safe or not please guide me thank you
my brother mr Anil gagare suffering from aplastic Anemia Last there years his platlate count is 55000ony can he take corona vaccine
"Major cause of infection is recipients own body" How, internally or externally from bad hygiene?